Drug intelligence / Profile preview

pentagastrin

Development stage
Unknown
Lead developer
Ferring Pharmaceuticals
Modality
Small Molecules, Peptides
Administration
Subcutaneous, Intramuscular, Intravenous
01

Overview

Pentagastrin is a synthetic polypeptide that mimics the actions of endogenous gastrin. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor by acting as an agonist at the cholecystokinin-B receptor (CCK-B), which is expressed in both the stomach and brain. Its primary clinical use is as a diagnostic aid for evaluating gastric acid secretory function, including testing for anacidity (achlorhydria) in patients with suspected pernicious anemia, atrophic gastritis, or gastric carcinoma. It is also used to assess reduction in acid output after surgical procedures such as vagotomy or gastric resection and can be used in stimulation tests for certain hormone-secreting tumors like Zollinger-Ellison syndrome[1][2][5]. When administered parenterally, it may provoke panic attacks due to its central nervous system effects[1]. The drug has a short elimination half-life of about 10 minutes[1][7].

Brand names
Peptavlon
Other names
PentagastrinaPentagastrine
02

Targets

CCK2R (Cholecystokinin 2 Receptor)

Beyond the preview

Go deeper on pentagastrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pentagastrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call